Adicet Bio, Inc.

Biotechnology • Healthcare • Boston, MA, United States • ACET (NCM)

Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. It offers gamma delta T cells engineered with chimeric antigen receptors (CARs) to facilitate durable activity in patients. The company's lead product candidate is ADI-001, an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, which is in Phase I clinical trial for the potential treatment of autoimmune diseases and relapsed/refractory B-cell non-hodgkin's lymphoma. It also develops ADI-270, an armored gamma delta CAR T cell product candidate to treat multiple CD70+ solid tumor and hematological malignancies indications, with renal cell carcinoma. The company was founded in 2014 and is based in Boston, Massachusetts.

650 503 9095 131 Dartmouth Street, Boston, MA 02116, United States

Stock Performance (90 Days)

Data through Dec 29, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Adicet Bio stock falls after announcing 1-for-16 reverse split - Investing.com

Investing.com • Dec 26

Adicet Bio Implements Reverse Stock Split to Maintain Listing - TipRanks

TipRanks • Dec 29

Adicet Bio To Implement 1-for-16 Reverse Stock Split On December 30 - Nasdaq

Nasdaq • Dec 26

Biotech shrinks share count 16 to 1—what changes for its shareholders - Stock Titan

Stock Titan • Dec 26

Adicet Bio Stock Scheduled to Reverse Split on Tuesday, December 30th (NASDAQ:ACET) - MarketBeat

MarketBeat • Dec 27

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Adicet Bio, Inc. had layoffs?

No layoff events have been recorded for Adicet Bio, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Adicet Bio, Inc. have?

Adicet Bio, Inc. has approximately 152 employees.

What industry is Adicet Bio, Inc. in?

Adicet Bio, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Adicet Bio, Inc. a publicly traded company?

Yes, Adicet Bio, Inc. is publicly traded under the ticker symbol ACET on the NCM. The company has a market capitalization of approximately $0.08 billion.

Where is Adicet Bio, Inc. headquartered?

Adicet Bio, Inc. is headquartered in Boston, MA, United States at 131 Dartmouth Street, Boston, MA 02116, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.